Published in TB and Outbreaks Week, August 29th, 2006
Dr Andrew Watts from the University of Bath (U.K.) and Dr Jennifer McKimm-Breschkin from CSIRO (Australia) have been awarded over £408,000 from the Medical Research Council (MRC) to develop a new class of inhibitor they have discovered into a new kind of antiviral influenza drug.
The search for an alternative flu drug has become all the more pressing as the full extent of resistance - the ability of the influenza virus to withstand drug treatments - becomes more...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week